ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01144637
Recruitment Status : Completed
First Posted : June 15, 2010
Last Update Posted : December 2, 2015
Sponsor:
Information provided by (Responsible Party):
Bavarian Nordic